JP2018533604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533604A5 JP2018533604A5 JP2018524447A JP2018524447A JP2018533604A5 JP 2018533604 A5 JP2018533604 A5 JP 2018533604A5 JP 2018524447 A JP2018524447 A JP 2018524447A JP 2018524447 A JP2018524447 A JP 2018524447A JP 2018533604 A5 JP2018533604 A5 JP 2018533604A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- arenavirus
- tumor
- protein
- segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021179213A JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562254654P | 2015-11-12 | 2015-11-12 | |
| US201562254651P | 2015-11-12 | 2015-11-12 | |
| US62/254,654 | 2015-11-12 | ||
| US62/254,651 | 2015-11-12 | ||
| PCT/EP2016/076668 WO2017080920A1 (en) | 2015-11-12 | 2016-11-04 | Arenavirus particles as cancer vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021179213A Division JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533604A JP2018533604A (ja) | 2018-11-15 |
| JP2018533604A5 true JP2018533604A5 (enExample) | 2020-04-09 |
| JP7157662B2 JP7157662B2 (ja) | 2022-10-20 |
Family
ID=57345877
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018524447A Active JP7157662B2 (ja) | 2015-11-12 | 2016-11-04 | 癌ワクチンとしてのアレナウイルス粒子 |
| JP2021179213A Pending JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021179213A Pending JP2022033736A (ja) | 2015-11-12 | 2021-11-02 | 癌ワクチンとしてのアレナウイルス粒子 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11266727B2 (enExample) |
| EP (2) | EP3373959B1 (enExample) |
| JP (2) | JP7157662B2 (enExample) |
| CN (1) | CN108697775B (enExample) |
| AU (1) | AU2016352572B2 (enExample) |
| CA (1) | CA3003548A1 (enExample) |
| CY (1) | CY1125526T1 (enExample) |
| DK (1) | DK3373959T3 (enExample) |
| ES (1) | ES2922981T3 (enExample) |
| HR (1) | HRP20221167T1 (enExample) |
| HU (1) | HUE059589T2 (enExample) |
| LT (1) | LT3373959T (enExample) |
| PL (1) | PL3373959T3 (enExample) |
| PT (1) | PT3373959T (enExample) |
| RS (1) | RS63546B1 (enExample) |
| SI (1) | SI3373959T1 (enExample) |
| WO (1) | WO2017080920A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103993012B (zh) | 2007-12-27 | 2023-01-10 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| RS61993B1 (sr) | 2013-12-03 | 2021-07-30 | Hookipa Biotech Gmbh | Cmv vakcine |
| ES2811093T3 (es) * | 2014-11-13 | 2021-03-10 | Univ Geneve | Arenavirus trisegmentados como vectores de vacunas |
| HK1246183A1 (zh) | 2015-06-10 | 2018-09-07 | Hookipa Biotech Gmbh | Hpv疫苗 |
| WO2018045029A1 (en) * | 2016-09-02 | 2018-03-08 | The United States Of America, As Represented By The Secretary Of The Army | Pan south american arenavirus live attenuated vaccine |
| WO2017076988A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| EP3373959B1 (en) | 2015-11-12 | 2022-06-29 | Hookipa Biotech GmbH | Arenavirus particles as cancer vaccines |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| CN110719788A (zh) * | 2017-04-07 | 2020-01-21 | 霍欧奇帕生物科技有限公司 | 治疗实体瘤的沙粒病毒颗粒 |
| US20210369635A1 (en) * | 2017-11-29 | 2021-12-02 | Adaptive Phage Therapeutics, Inc. | Novel methods of vaccination using icosahedral phage |
| WO2020255023A1 (en) | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof |
| CN114981443A (zh) * | 2019-11-07 | 2022-08-30 | 巴塞尔大学 | 作为载体的沙粒病毒 |
| EP4069271A1 (en) | 2019-12-07 | 2022-10-12 | ISA Pharmaceuticals B.V. | Treatment of diseases related to hepatitis b virus |
| IL298420A (en) | 2020-05-29 | 2023-01-01 | Hookipa Biotech Gmbh | Cancer treatment strategies using RNA virus vectors |
| WO2022180203A1 (en) * | 2021-02-26 | 2022-09-01 | Abalos Therapeutics Gmbh | New virus particles for therapeutic purposes |
| MX2023011054A (es) | 2021-03-23 | 2023-11-22 | Hookipa Biotech Gmbh | Arenavirus utilizados en tratamientos del cáncer de próstata. |
| EP4475879A1 (en) * | 2022-02-08 | 2024-12-18 | Hookipa Biotech GmbH | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines |
| EP4701650A2 (en) | 2023-04-26 | 2026-03-04 | Isabella Pharma B.V. | Methods of treating cancer by administering immunogenic compositions and a pd-1 inhibitor |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| JPH1084967A (ja) | 1996-09-19 | 1998-04-07 | Fujirebio Inc | Ｂ型肝炎のｅ抗原 |
| FR2803599B1 (fr) | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| DE60334303D1 (de) * | 2002-07-03 | 2010-11-04 | Tasuku Honjo | Immunpotenzierende zusammensetzungen |
| EP3530736A3 (en) | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| WO2006125983A1 (en) | 2005-05-23 | 2006-11-30 | Oxxon Therapeutics Ltd | Compositions for inducing an immune response against hepatitis b |
| CA2646891A1 (en) | 2006-03-23 | 2007-09-27 | Novartis Ag | Immunopotentiating compounds |
| ATE539079T1 (de) | 2006-03-23 | 2012-01-15 | Novartis Ag | Imidazochinoxalinverbindungen als immunmodulatoren |
| CA2673870A1 (en) * | 2006-12-27 | 2008-07-10 | Emory University | Compositions and methods for the treatment of infections and tumors |
| CN103993012B (zh) * | 2007-12-27 | 2023-01-10 | 苏黎士大学 | 复制缺陷型沙粒病毒载体 |
| CA2770075C (en) | 2009-08-07 | 2021-08-24 | Perrine Martin | Composition for treating hbv infection |
| GB201001726D0 (en) | 2010-02-03 | 2010-03-24 | Univ St Andrews | Bunyavirus vaccine |
| WO2012162428A1 (en) | 2011-05-23 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prime-boost vaccination for viral infection |
| CN104159607A (zh) | 2012-01-24 | 2014-11-19 | 桑福德研究院/南达科他大学 | 用于治疗致癌病毒多肽阳性肿瘤的多核苷酸 |
| US9809801B2 (en) | 2013-03-15 | 2017-11-07 | Université De Genève | Anti-mycobacterial vaccines |
| GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
| RS61993B1 (sr) | 2013-12-03 | 2021-07-30 | Hookipa Biotech Gmbh | Cmv vakcine |
| WO2015103602A1 (en) * | 2014-01-06 | 2015-07-09 | The Trustees Of The University Of Pennsylvania | Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy |
| US10342861B2 (en) | 2014-05-27 | 2019-07-09 | University Of Rochester | Arenavirus vaccine |
| US9943585B2 (en) | 2014-07-30 | 2018-04-17 | University Of Rochester | Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV) |
| BR112017005744B1 (pt) | 2014-09-22 | 2023-11-28 | Regents Of The University Of Minnesota | "vírus pichinde geneticamente manipulado, método de fabricação e uso do mesmo, partícula viral infecciosa, composição, coleção de vetores, sistema de genética reversa e método de uso do mesmo" |
| GB201419572D0 (en) | 2014-11-03 | 2014-12-17 | Pirbright Inst The | Virus |
| ES2811093T3 (es) * | 2014-11-13 | 2021-03-10 | Univ Geneve | Arenavirus trisegmentados como vectores de vacunas |
| KR102698184B1 (ko) * | 2015-01-29 | 2024-08-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 관문 억제제 및 백신 조합 및 면역요법을 위한 이들의 사용 |
| DE102015207036A1 (de) | 2015-04-17 | 2016-10-20 | Karl Sebastian Lang | Arenaviren zur Anwendung bei der Behandlung und/oder Vorbeugung von Tumoren sowie Verfahren zur Herstellung von Arenaviren mit (verbesserten) tumorregressiven Eigenschaften |
| HK1246183A1 (zh) | 2015-06-10 | 2018-09-07 | Hookipa Biotech Gmbh | Hpv疫苗 |
| US10849969B2 (en) | 2015-10-23 | 2020-12-01 | Institut Pasteur | Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity |
| WO2017076988A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| EP3373959B1 (en) | 2015-11-12 | 2022-06-29 | Hookipa Biotech GmbH | Arenavirus particles as cancer vaccines |
| WO2017190074A1 (en) | 2016-04-28 | 2017-11-02 | The University Of Chicago | Lymphangiogenesis for therapeutic immunomodulation |
| IL262963B2 (en) | 2016-05-18 | 2025-01-01 | Hookipa Biotech Gmbh | Trisegmented PICHINDE viruses as vaccine vectors |
| CN110167586B (zh) | 2016-11-04 | 2024-01-30 | 霍欧奇帕生物科技有限公司 | 作为癌症疫苗的复制-缺陷型沙粒病毒颗粒和三-节段沙粒病毒颗粒 |
| CN110719788A (zh) | 2017-04-07 | 2020-01-21 | 霍欧奇帕生物科技有限公司 | 治疗实体瘤的沙粒病毒颗粒 |
| CN114981443A (zh) | 2019-11-07 | 2022-08-30 | 巴塞尔大学 | 作为载体的沙粒病毒 |
-
2016
- 2016-11-04 EP EP16797775.0A patent/EP3373959B1/en active Active
- 2016-11-04 US US15/775,360 patent/US11266727B2/en active Active
- 2016-11-04 CA CA3003548A patent/CA3003548A1/en active Pending
- 2016-11-04 RS RS20220825A patent/RS63546B1/sr unknown
- 2016-11-04 HR HRP20221167TT patent/HRP20221167T1/hr unknown
- 2016-11-04 PL PL16797775.0T patent/PL3373959T3/pl unknown
- 2016-11-04 CN CN201680078633.1A patent/CN108697775B/zh active Active
- 2016-11-04 ES ES16797775T patent/ES2922981T3/es active Active
- 2016-11-04 HU HUE16797775A patent/HUE059589T2/hu unknown
- 2016-11-04 PT PT167977750T patent/PT3373959T/pt unknown
- 2016-11-04 DK DK16797775.0T patent/DK3373959T3/da active
- 2016-11-04 JP JP2018524447A patent/JP7157662B2/ja active Active
- 2016-11-04 WO PCT/EP2016/076668 patent/WO2017080920A1/en not_active Ceased
- 2016-11-04 SI SI201631604T patent/SI3373959T1/sl unknown
- 2016-11-04 LT LTEPPCT/EP2016/076668T patent/LT3373959T/lt unknown
- 2016-11-04 AU AU2016352572A patent/AU2016352572B2/en active Active
- 2016-11-04 EP EP21182026.1A patent/EP3960197A1/en not_active Withdrawn
-
2021
- 2021-11-02 JP JP2021179213A patent/JP2022033736A/ja active Pending
-
2022
- 2022-01-24 US US17/582,682 patent/US20220257734A1/en not_active Abandoned
- 2022-09-01 CY CY20221100585T patent/CY1125526T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20221167T1 (hr) | Čestice arenavirusa kao cjepiva protiv raka | |
| JP2023029898A5 (enExample) | ||
| US20200113995A1 (en) | Arenavirus particles to treat solid tumors | |
| JP2019533690A5 (enExample) | ||
| CN118146379B (zh) | 一种改善免疫应答细胞功能的方法 | |
| US11207339B2 (en) | Targeted cancer therapy | |
| JP2023029898A (ja) | 癌ワクチンとしての複製欠損性アレナウイルス粒子及び３セグメント型アレナウイルス粒子 | |
| CN114981443A (zh) | 作为载体的沙粒病毒 | |
| JP2023500928A5 (enExample) | ||
| HK40070799A (en) | Arenavirus particles as cancer vaccines | |
| US20250057931A1 (en) | Combination therapy with arenavirus particles and immune checkpoint modulators or cytokines | |
| HK1260579A1 (en) | Arenavirus particles as cancer vaccines | |
| HK1260579B (en) | Arenavirus particles as cancer vaccines | |
| Bonnekoh et al. | SYSTEMIC ANTI-TUMOR IMMUNE DEFENSE IN THE MOUSE B16 MELANOMA MODEL |